Medina S, Sainz de la Maza S, Villarrubia N, Álvarez-Lafuente R, Costa-Frossard L, Arroyo R, Monreal E, Tejeda-Velarde A, Rodríguez-Martín E, Roldán E, Álvarez-Cermeño JC, Villar LM.

Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients.

Annals of Clinical and Translational Neurology 2019. 6(2): 355-363. Nº de citas: 10

[doi:10.1002/acn3.711]

Tejeda Velarde, Amalia, Medina Heras, Silvia, Villar Guimerans, Luisa Maria.

Biomarkers for Multiple Sclerosis

RSC Drug Discovery Series 2019. 70: 55-75.

[doi:10.1039/9781788016070]

Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, Segundo DS, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM.

Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.

CLINICA CHIMICA ACTA 2019. 488: 135-142. Nº de citas: 1

[doi:10.1016/j.cca.2018.11.008]

Malhotra S, Villar LM, Costa C, Midaglia L, Cubedo M, Medina S, Fissolo N, Río J, Castilló J, Álvarez-Cermeño JC, Sánchez A, Montalban X, Comabella M.

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.

JOURNAL OF NEUROINFLAMMATION 2018. 15(1): 296-296. Nº de citas: 5

[doi:10.1186/s12974-018-1336-9]

Perez Perez, S., Dominguez Mozo, M. I., Medina, S., Villarubia, N., Alonso Gomez, A., Garcia Martinez, M. A., Costa Frossard, L., Alvarez Cermeno, J. C., Arroyo Gonzalez, R., Villar Guimerans, L. M., Alvarez Lafuente, R..

Short chain fatty acids levels in plasma of multiple sclerosis patients: a correlation with the disability of the disease and the activation of the immune system

MULTIPLE SCLEROSIS JOURNAL 2018. 24: 601-602. Nº de citas: 1

Alonso-Canovas A, Lopez-Sendon Moreno JL, Buisan J, Sainz de la Maza S, Costa-Frossard L, Garcia-Ribas G, de Felipe-Mimbrera A, Matute-Lozano MC, Zarza Sanz B, Toledano Delgado R, Corral I, Masjuan J, Martinez-Castrillo JC.

Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.

JOURNAL OF NEUROLOGY 2018. 265(10): 2363-2369. Nº de citas: 3

[doi:10.1007/s00415-018-9006-5]

Malhotra S, Sorosina M, Río J, Peroni S, Midaglia L, Villar LM, Álvarez-Cermeño JC, Schroeder I, Esposito F, Clarelli F, Zettl UK, Lechner-Scott J, Spataro N, Navarro A, Comi G, Montalban X, Martinelli-Boneschi F, Comabella M.

NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients.

MULTIPLE SCLEROSIS JOURNAL 2018. 24(11): 1507-1510. Nº de citas: 6

[doi:10.1177/1352458517739137]

Gil-Varea E, Urcelay E, Vilariño-Güell C, Costa C, Midaglia L, Matesanz F, Rodríguez-Antigüedad A, Oksenberg J, Espino-Paisan L, Dessa Sadovnick A, Saiz A, Villar LM, García-Merino JA, Ramió-Torrentà L, Triviño JC, Quintana E, Robles R, Sánchez-López A, Arroyo R, Alvarez-Cermeño JC, Vidal-Jordana A, Malhotra S, Fissolo N, Montalban X, Comabella M.

Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course.

JOURNAL OF NEUROINFLAMMATION 2018. 15(1): 265-265. Nº de citas: 17

[doi:10.1186/s12974-018-1307-1]

Quintana E, Coll C, Salavedra-Pont J, Muñoz-San Martín M, Robles-Cedeño R, Tomàs-Roig J, Buxó M, Matute-Blanch C, Villar LM, Montalban X, Comabella M, Perkal H, Gich J, Ramió-Torrentà LL.

Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain.

EUROPEAN JOURNAL OF NEUROLOGY 2018. 25(9): 1189-1191. Nº de citas: 36

[doi:10.1111/ene.13687]

Medina S, Villarrubia N, Sainz de la Maza S, Lifante J, Costa-Frossard L, Roldán E, Picón C, Álvarez-Cermeño JC, Villar LM.

Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.

MULTIPLE SCLEROSIS JOURNAL 2018. 24(10): 1317-1327. Nº de citas: 30

[doi:10.1177/1352458517717088]

Szejko N, Picón C, García-Caldentey J, de Yebenes JG, Alvarez-Cermeño JC, Villar LM, López-Sendón Moreno JL.

Quantification of the Light Subunit of Neurofilament Protein in Cerebrospinal Fluid of Huntington's Disease Patients.

PLoS currents 2018. 10: .

[doi:10.1371/currents.hd.280c8f9f7d9fa4f7f0c883d9f8e807da]

Casanova B, Lacruz L, Villar ML, Domínguez JA, Gadea MC, Gascón F, Mallada J, Hervás D, Simó-Castelló M, Álvarez-Cermeño JC, Calles C, Olascoaga J, Ramió-Torrentà L, Alcalá C, Cervelló A, Boscá I, Pérez-Mirallles FC, Coret F.

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients.

NEUROLOGICAL SCIENCES 2018. 39(8): 1423-1430. Nº de citas: 4

[doi:10.1007/s10072-018-3442-y]

Alari-Pahissa E, Moreira A, Zabalza A, Alvarez-Lafuente R, Munteis E, Vera A, Arroyo R, Alvarez-Cermeño JC, Villar LM, López-Botet M, Martínez-Rodríguez JE.

Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the 'hygiene hypothesis'?

EUROPEAN JOURNAL OF NEUROLOGY 2018. 25(7): 925-933. Nº de citas: 12

[doi:10.1111/ene.13622]

Corral Í, Sainz de la Maza S, Rodríguez M, Kawiorski MM, López-Martínez MJ, Galán JC.

Molecular detection of human herpesvirus 7 DNA in cerebrospinal fluid from adult patients with neurological disorders.

JOURNAL OF NEUROVIROLOGY 2018. 24(3): 333-338. Nº de citas: 5

[doi:10.1007/s13365-018-0618-4]

Ramió-Torrentà L, Álvarez-Cermeño JC, Arroyo R, Casanova-Estruch B, Fernández O, García-Merino JA, Hernández MA, Izquierdo G, Martínez-Yélamos S, Meca J, Moral E, Olascoaga J, Prieto JM, Saiz A.

A guide to treating gait impairment with prolonged-release fampridine (Fampyra (R)) in patients with multiple sclerosis

NEUROLOGIA 2018. 33(5): 327-337. Nº de citas: 2

[doi:10.1016/j.nrl.7015.11.013]

Bravo García-Morato M, Aracil Santos FJ, Briones AC, Blázquez Moreno A, Del Pozo Maté Á, Domínguez-Soto Á, Beato Merino MJ, Del Pino Molina L, Torres Canizales J, Marin AV, Vallespín García E, Feito Rodríguez M, Plaza López Sabando D, Jiménez-Reinoso A, Mozo Del Castillo Y, Sanz Santaeufemia FJ, de Lucas-Laguna R, Cárdenas PP, Casamayor Polo L, Coronel Díaz M, Valés-Gómez M, Roldán Santiago E, Ferreira Cerdán A, Nevado Blanco J, Corbí ÁL, Reyburn HT, Regueiro JR, López-Granados E, Rodríguez Pena R.

New human combined immunodeficiency caused by interferon regulatory factor 4 (IRF4) deficiency inherited by uniparental isodisomy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2018. 141(5): 1924. Nº de citas: 8

[doi:10.1016/j.jaci.2017.12.995]

Matute-Blanch C, Villar LM, Álvarez-Cermeño JC, Rejdak K, Evdoshenko E, Makshakov G, Nazarov V, Lapin S, Midaglia L, Vidal-Jordana A, Drulovic J, García-Merino A, Sánchez-López AJ, Havrdova E, Saiz A, Llufriu S, Alvarez-Lafuente R, Schroeder I, Zettl UK, Galimberti D, Ramió-Torrentà L, Robles R, Quintana E, Hegen H, Deisenhammer F, Río J, Tintoré M, Sánchez A, Montalban X, Comabella M.

Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.

Brain 2018. 141(4): 1085-1093. Nº de citas: 71

[doi:10.1093/brain/awy021]

Tejeda-Velarde A, Costa-Frossard L, de la Maza SS, Carrasco Á, Espiño M, Picón C, Toboso I, Walo PE, Lourido D, Muriel A, Álvarez-Cermeño JC, Villar LM.

Clinical usefulness of prognostic biomarkers in optic neuritis.

EUROPEAN JOURNAL OF NEUROLOGY 2018. 25(4): 614-618. Nº de citas: 10

[doi:10.1111/ene.13553]